PPT-Abuse Deterrent Opioids: The Promise and the perils

Bob Twillman PhD FAPM Executive Director American Academy of Pain Management Two Major Public Health Problems Prescription opioid abuse 125 million nonmedical users per year 70120 billion cost per year. The Child Ab use Prevention and Treatment Act CAPTA has these definitions Child abuse and neglect At a minimum any recent act or failure to act o n the part of a parent or caretaker which results in death serious physical or emotional harm sexual a Withdrawal 1991 Bush Admin Withdrawal 1992 Joint Declaration of the 1992 Joint Declaration of the Denuclearization of the Korean Peninsula Denuclearization of the Korean Peninsula Nuclear Extended Deterrence Nuclear Extended Deterrence brPage 4br Caitlin Hughes,. ¹ . Don Weatherburn. ². , Robert . MacCoun. . 3. ¹ . National Drug and Alcohol Research Centre, UNSW Australia. ² . NSW Bureau of Crime Statistics and Research. 3. . Berkeley School of Law, University of . Outpatient Opioid Therapy: Mitigating Risks. Perry G. Fine, MD . Professor . of Anesthesiology. Department . of . Anesthesiology . School . of Medicine. University of Utah. O. bjectives. Be informed of content, intent and limitation of current Clinical Guidelines. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. challenges, risks, and negotiations. Mark Sullivan, MD, PhD. University of Washington. Psychiatry and Behavioral Sciences. Anesthesiology and Pain Medicine. Bioethics and Humanities. CME grant from REMS-RPC to disseminate COPE-REMS training. Performance: . A Review of Findings for the Medical . Review Board. July . 29, . 2014. Roadmap. Purpose. Background. Overview of Research Questions . Search Methodology . Q1a . Q1b . Q2 . Q3 . Conclusion. Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Joshua P. Cohen, PhD. Massachusetts State House. February 5, 2018. 20% of non-cancer pain patients are prescribed an . opioid. , compared to <5% in other industrialized nations. U.S. has 4% of the world’s population, yet 30% of global . Bureau of Health Care Safety and Quality. Department of Public Health. July 14, 2016. Review of June 2. nd. meeting. Non-Opioid Pain Management List. . Draft Formulary Guidance. Next Steps. Slide . Fatima Sheikh, MD, MPH, CMD . Alva S. Baker, MD, CMDR, HMDC. November 10, 2018. Speaker Disclosures. Dr. Sheikh has disclosed that she has no relevant financial relationship(s). . Dr. Baker has disclosed that he has no relevant financial relationship(s). . Effectiveness and Value. Presentation to the Massachusetts Drug Formulary Commission. February 5, 2018. Presentation Agenda. Introduction to ICER. Comparative clinical effectiveness of abuse-deterrent formulations of opioids (ADFs). How Will Ketchikan Respond?. “The . opioid epidemic is devastating American families and communities. To curb these trends and save lives, . we must help prevent addiction and provide support and treatment . Immersion Training in Addiction Medicine Programs 2021. May 2021. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit.